biote Corp.
BTMD
$3.22
$0.206.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.62% | 4.67% | 9.04% | 12.79% | -0.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.62% | 4.67% | 9.04% | 12.79% | -0.18% |
| Cost of Revenue | -9.67% | -6.26% | 2.13% | 7.09% | -2.95% |
| Gross Profit | 3.49% | 9.08% | 12.09% | 15.36% | 1.13% |
| SG&A Expenses | -10.99% | 16.43% | 24.37% | 15.18% | 23.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.52% | 8.04% | 16.25% | 11.84% | 12.60% |
| Operating Income | 63.48% | -7.07% | -28.67% | 15.69% | -42.47% |
| Income Before Tax | 159.01% | 625.12% | -113.07% | -32.58% | 15.43% |
| Income Tax Expenses | 2,845.21% | -32.72% | -71.39% | -17.45% | -92.08% |
| Earnings from Continuing Operations | 137.86% | 376.62% | -71.16% | -35.56% | 20.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -122.55% | -235.53% | 105.06% | 83.86% | -58.74% |
| Net Income | 144.94% | 429.68% | -52.12% | 42.12% | -37.80% |
| EBIT | 63.48% | -7.07% | -28.67% | 15.69% | -42.47% |
| EBITDA | 59.68% | -4.92% | -23.85% | 15.64% | -39.52% |
| EPS Basic | 146.99% | 462.48% | -47.98% | 38.88% | 13.73% |
| Normalized Basic EPS | -29.77% | -67.85% | 1,271.23% | 165.20% | -45.96% |
| EPS Diluted | 146.66% | 407.82% | -17.28% | 37.50% | 14.28% |
| Normalized Diluted EPS | -30.05% | -72.62% | 1,938.46% | 164.18% | -45.96% |
| Average Basic Shares Outstanding | -4.37% | -9.06% | -7.95% | 2.34% | 59.73% |
| Average Diluted Shares Outstanding | -4.02% | 6.74% | -41.14% | 3.93% | 59.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.85% | -- | -- | -0.68% | 0.14% |